Literature DB >> 2396258

HLA antigens in cancer of the gallbladder.

M Yamamoto1, M Haga, S Takagi, K Endoh, S Ito, K Yoshida, K Kato, S Akai.   

Abstract

Thirty one patients with gallbladder cancer (GBC) and 32 healthy controls were typed using antisera against 12 HLA-A, 31 HLA-B, 7 HLA-C and 13 HLA-DR antigens. The DR4 frequency of 61.3% (19/31) in GBC was significantly different from that of 28.1% (9/32) in the control (p = 0.00794 by Fisher's exact test). The relative risk and the etiologic fraction were 4.0 and 0.46, respectively.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2396258     DOI: 10.1620/tjem.161.69

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  2 in total

1.  A genetic polymorphism of CYP2C19 is associated with susceptibility to biliary tract cancer.

Authors:  Yoshihiro Isomura; Yutaka Yamaji; Miki Ohta; Motoko Seto; Yoshinari Asaoka; Yasuo Tanaka; Takashi Sasaki; Yousuke Nakai; Naoki Sasahira; Hiroyuki Isayama; Minoru Tada; Haruhiko Yoshida; Takao Kawabe; Masao Omata; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2010-06-12       Impact factor: 7.527

2.  Epidemiological studies on the distribution and determinants of biliary tract cancer.

Authors:  Masaharu Yamamoto
Journal:  Environ Health Prev Med       Date:  2003-01       Impact factor: 3.674

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.